Campaigning & Advocacy

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Our campaigns

We run campaigns throughout the year, and need you to get involved and help raise awareness.

What is campaigning and advocacy?

As a charity we are actively involved in campaigning on behalf of patients and their carers, which we feel is an important part of the work that we do. We are passionate about doing everything we can to improve the experience of patients throughout their cancer journey.

Know your rights toolkit

We have produced a number of bitesize pieces of information to help you understand the options that are available to you, access further information and make informed decisions.

Patient Advocacy Groups

We are involved with a number of organisations and coalitions on your behalf which, through collaborative working, aim to ensure that the collective voice of blood cancer patients is heard.

Working with the pharmaceutical industry

We work with the pharmaceutical industry to ensure that they take the interests of patients into account when developing new drugs and treatments for blood cancer patients.

Health Technology Appraisals

This involves working with bodies such as the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) to ensure that the views of patients are taken into account when making decisions over access to drugs and treatments.

Nurse Academy e-learning

We have a number of free courses available for haematology nurses to complete and use towards their continued professional development (CPD).

Read More

Take a Moment to Catch Up

View our latest news and blog articles

July 25th

NEW oral treatment for ALL patients approved in Scotland

Leukaemia Care are pleased to announce that adult patients with philadelphia chromosome–positive (Ph+) acute lymphoblastic leukaemia (ALL) now have access to Dasatinib thanks to the decision made by the National Cancer Medicines Advisory Group (NCMAG) today....

July 12th

Gordon Waring: My Fundraising Story

Gordon took on his own walking challenge to raise vital funds for Leukaemia Care after his stepson was diagnosed with acute myeloid leukaemia (AML) at 37 years old. Here, he talks about how the family’s life has since been turned upside down and how the walk also gave him the opportunity to reflect on his own journey. ...

July 5th

General Election result vs Leukaemia Care’s manifesto

With the 2024 general election over, Charlotte, Leukaemia Care's Policy and Evidence Manager shares how we plan to work with the future government to improve early diagnosis rates of cancers like leukaemia and improve cancer care....